Technologies
Our technology is about aligning the modern drug discovery process with advances in engineering to harvest the natural chemical pharmacopeia available in the natural world.
pharm·ma·cog·no·sy | (noun)
Knowledge concerned with medicinal drugs obtained from plants or other natural sources.
Microbial Diversity
There are an estimated 1 trillion
microbial species.
300,000+ plant species described but only about 6% investigated pharmacologically. EMS Genomics overcomes the random screening mindset.
Systems
Bioprospecting
Medicinal properties are not evenly distributed through plant, animal, and microbes. Random screening of extracts, fractions, and isolates are incoherent.
EMS Genomics prospects with biological and investigative coherence
The EMS Genomics discovery pipeline in action: The value proposition lies in our ability to target species fitness. We do this through a unique set of tools and instruments developed in our lab. We interrogate organisms in vivo and unfold their traits at specific times in the lifecycle when they are exhibiting the trait we are most after. Then we identify the molecular basis of fitness by characterizing the genes and molecules that make the organism unique
Our bioprospecting in action for cell regulation and DNA repair
